Afsaneh Lavasanifar

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Venues

Molecular pharmaceutics

ACS bio & med chem Au

Bioengineering (Basel, Switzerland)

The journal of physical chemistry. B

University of Alberta (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Alberta Sep 01 1996

Canada

PHD :: Pharmaceutical Sciences

Publications

Sams M A Sadat, Mohammad Reza Vakili, Sara I Abd-El Hafeez, Marco Paladino, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. Molecular pharmaceutics (2024)
Prashant Pandey, Dilip Kumar Arya, Payal Deepak, Daoud Ali, Saud Alarifi, Saurabh Srivastava, Afsaneh Lavasanifar, Paruvathanahalli Siddalingam Rajinikanth
αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment. Bioengineering (Basel, Switzerland) 11 (8) (2024)
Sams M A Sadat, Mohammad Reza Vakili, Sara I Abd-El Hafeez, Marco Paladino, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. Molecular pharmaceutics 21 (7) (2024)
Prashant Pandey, Dilip Kumar Arya, Payal Deepak, Daoud Ali, Saud Alarifi, Saurabh Srivastava, Afsaneh Lavasanifar, Paruvathanahalli Siddalingam Rajinikanth
αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment. Bioengineering (Basel, Switzerland) 11 (8) (2024)
Soheyl Tadjiki, Shahriar Sharifi, Afsaneh Lavasanifar, Morteza Mahmoudi
Advancing In Situ Analysis of Biomolecular Corona: Opportunities and Challenges in Utilizing Field-Flow Fractionation. ACS bio & med chem Au 4 (2) (2024)
Soheyl Tadjiki, Shahriar Sharifi, Afsaneh Lavasanifar, Morteza Mahmoudi
Advancing In Situ Analysis of Biomolecular Corona: Opportunities and Challenges in Utilizing Field-Flow Fractionation. ACS bio & med chem Au 4 (2) (2024)
Soheyl Tadjiki, Shahriar Sharifi, Afsaneh Lavasanifar, Morteza Mahmoudi
Advancing In Situ Analysis of Biomolecular Corona: Opportunities and Challenges in Utilizing Field-Flow Fractionation. ACS bio & med chem Au 4 (2) (2024)
Sams M A Sadat, Mohammad Reza Vakili, Sara I Abd-El Hafeez, Marco Paladino, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. Molecular pharmaceutics 21 (7) (2024)
Ziyad Binkhathlan, Raisuddin Ali, Abdullah H Alomrani, Mohd Abul Kalam, Aws Alshamsan, Afsaneh Lavasanifar
Role of Polymeric Micelles in Ocular Drug Delivery: An Overview of Decades of Research. Molecular pharmaceutics (2023)
Elmira Ziaei, Igor Moura de Paiva, Shih-Jing Yao, Nasim Sarrami, Parnian Mehinrad, Justine Lai, Afsaneh Lavasanifar, Kamaljit Kaur
Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice. Molecular pharmaceutics (2023)
Afsaneh Lavasanifar, Lynne S Taylor
Shedding Light on the Elephant in a Dark Room in the Discovery of New Medicine: Highlighting Molecular Pharmaceutics within ACS Bio & Med Chem Au . ACS bio & med chem Au 2 (4) (2022)
Afsaneh Lavasanifar, Lynne S Taylor
Shedding Light on the Elephant in a Dark Room in the Discovery of New Medicine: Highlighting Molecular Pharmaceutics within ACS Bio & Med Chem Au . ACS bio & med chem Au 2 (4) (2022)
Igor Moura de Paiva, Mohammad Reza Vakili, Amir Hasan Soleimani, Seyed Amirhossein Tabatabaei Dakhili, Sirazum Munira, Marco Paladino, Gary Martin, Frank R Jirik, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis. Molecular pharmaceutics 19 (6) (2022)
Alessandra Spada, Jaber Emami, Jack Adam Tuszynski, Afsaneh Lavasanifar
The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. Molecular pharmaceutics 18 (5) (2021)
Lynne S Taylor, Christel A S Bergstrom, Afsaneh Lavasanifar, Feng Qian, Raj Suryanarayanan, Kristofer J Thurecht
Celebrating Women in the Pharmaceutical Sciences. Molecular pharmaceutics 18 (4) (2021)
Reza Talandashti, Faramarz Mehrnejad, Kiana Rostamipour, Farahnoosh Doustdar, Afsaneh Lavasanifar
Molecular Insights into Pore Formation Mechanism, Membrane Perturbation, and Water Permeation by the Antimicrobial Peptide Pleurocidin: A Combined All-Atom and Coarse-Grained Molecular Dynamics Simulation Study. The journal of physical chemistry. B 125 (26) (2021)
Squire J Booker, Stuart J Conway, Afsaneh Lavasanifar
Welcome to ACS Bio & Med Chem Au . ACS bio & med chem Au 1 (1) (2021)
Hanan Al-Lawati, Mohammad Reza Vakili, Afsaneh Lavasanifar, Surur Ahmed, Fakhreddin Jamali
Reduced Heart Exposure of Diclofenac by Its Polymeric Micellar Formulation Normalizes CYP-Mediated Metabolism of Arachidonic Acid Imbalance in An Adjuvant Arthritis Rat Model: Implications in Reduced Cardiovascular Side Effects of Diclofenac by Nanodrug Delivery. Molecular pharmaceutics 17 (4) (2020)
Igor Paiva, Stephanie Mattingly, Melinda Wuest, Samantha Leier, Mohammad Reza Vakili, Michael Weinfeld, Afsaneh Lavasanifar, Frank Wuest
Synthesis and Analysis of 64Cu-Labeled GE11-Modified Polymeric Micellar Nanoparticles for EGFR-Targeted Molecular Imaging in a Colorectal Cancer Model. Molecular pharmaceutics 17 (5) (2020)
Ashkan H Rad, Farshid Asiaee, Sevda Jafari, Ali Shayanfar, Afsaneh Lavasanifar, Ommoleila Molavi
Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin. BioImpacts : BI 10 (2) (2019)
Amir H Soleimani, Shyam M Garg, Igor M Paiva, Mohammad R Vakili, Abdulraheem Alshareef, Yung-Hsing Huang, Ommoleila Molavi, Raymond Lai, Afsaneh Lavasanifar
Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma. Drug delivery and translational research 7 (4) (2018)
Zahra Shire, Mohammad Reza Vakili, Timothy D R Morgan, Dennis G Hall, Afsaneh Lavasanifar, Michael Weinfeld
Nanoencapsulation of Novel Inhibitors of PNKP for Selective Sensitization to Ionizing Radiation and Irinotecan and Induction of Synthetic Lethality. Molecular pharmaceutics 15 (6) (2018)
Hui-Na Liu, Ning-Ning Guo, Tian-Tian Wang, Wang-Wei Guo, Meng-Ting Lin, Ming-Yi Huang-Fu, Mohammad Reza Vakili, Wen-Hong Xu, Jie-Jian Chen, Qi-Chun Wei, Min Han, Afsaneh Lavasanifar, Jian-Qing Gao
Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies. Molecular pharmaceutics 15 (3) (2018)
Shyam M Garg, Mohammad Reza Vakili, Ommoleila Molavi, Afsaneh Lavasanifar
Self-Associating Poly(ethylene oxide)-block-poly(α-carboxyl-ε-caprolactone) Drug Conjugates for the Delivery of STAT3 Inhibitor JSI-124: Potential Application in Cancer Immunotherapy. Molecular pharmaceutics 14 (8) (2017)
Marco A Deriu, Michela Cangiotti, Gianvito Grasso, Ginevra Licandro, Afsaneh Lavasanifar, Jack A Tuszynski, Maria Francesca Ottaviani, Andrea Danani
Self-Assembled Ligands Targeting TLR7: A Molecular Level Investigation. Langmuir : the ACS journal of surfaces and colloids 33 (50) (2017)
Yogita Raghuwanshi, Hashem Etayash, Rania Soudy, Igor Paiva, Afsaneh Lavasanifar, Kamaljit Kaur
Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting. Journal of medicinal chemistry 60 (12) (2017)
Hoda Soleymani Abyaneh, Mohammad Reza Vakili, Alireza Shafaati, Afsaneh Lavasanifar
Block Copolymer Stereoregularity and Its Impact on Polymeric Micellar Nanodrug Delivery. Molecular pharmaceutics 14 (8) (2017)

Afsaneh Lavasanifar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Afsaneh Lavasanifar